 BOSTON, MA ACCESSWIRE November 11, 2021 Pieris Pharmaceuticals, Inc. NASDAQ:PIRS , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer, and other indications, today announced that members of the management team will participate in the following upcoming investor conferences: Jefferies London Healthcare Conference Thursday, November 18, 2021 at 8:00 AM GMT. A webcast of the Companys fireside chat will be available at this link. 